Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

NCT01064518 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Lateral Canthal Lines
Crow's Feet
Facial Wrinkles

Interventions

DRUG: Botulinum Toxin Type A
DRUG: Placebo (Dose B)

Sponsor

Revance Therapeutics, Inc.